|
|
|
|
|
|
Jinan Mingxin Pharmaceutical Co., Ltd owns over 30 varieties of products, including the leading Active Pharmaceutical Ingredients (API’s) Inosine, Ribavirin, Adenosine Triphosphate Disodium, Buflomedil Hydrochloric, Terbinafine Hydrochloride, Adenosine Cyclophosphate , Pantoprazole Sodium, Nateglinide, etc.; the leading pharmaceutical intermediates (PI’s) Tetraacetyl Ribose, Adenosine, Cytidine, Hypoxanthine, Phenazepam, etc.; the leading preparations Matrine tablets, Omeprazole Enteric-coated capsules, Adenosine Disodium Triphosphate tablets, Inosine tablets, Buflomedil tablets, Terbinafine tablets and so on..All drugs produced by the company have got national approval and GMP certificates. Several products are registered abroad, like Inosine, Ribavirin, etc. All products are not only selling in domestic market very well, but also in foreign market such as the United States, Canada, Britain, Italy, Russia, Japan, India and others. Product quality and services have gained wide reputation.
To promote the development, the company has signed long-term cooperation agreement with Tsinghua University, East China University of Science and Technology, and Shandong Academy of Medical Sciences focusing on research and development of new drugs. The company is going to increase 4-6 newly developed drugs annually to become one of the strongest pharmaceutical enterprises.
Persisting on the principle "Develop Mingxin Pharmacy, Benefit the People's Health!", the company constantly strengthens the enterprise core competitive power, and strives to make due efforts and contributions for the progress of the Chinese pharmaceutical industry. |
|
|
| inosine, nateglinide, ribavirin, ATP disodium, Buflomedil HCL, Terbinafine HCL, Adenosine Cyclophosphate, Pantoprazole DIsodium, Inosine tablets, ATP tablets, matrine tablets, Omeprazole Enteric-Coated Capsules |
|
|
| Company : |
Jinan Mingxin Pharmaceutical Co., Ltd. |
| Email: |
Contact us |
| URL: |
********
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
